These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 6110451)

  • 21. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
    Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
    Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of alpha-adrenoceptor antagonists administered intraventricularly on central hypotensive action of clonidine and on central hypertensive action of methoxamine in rabbits.
    Kim YI; Paik YH; Kang SS; Kim JH
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):66-76. PubMed ID: 6126161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation.
    Hikasa Y; Abe M; Satoh T; Hisashi Y; Ogasawara S; Matsuda H
    Pharmacology; 1999 Apr; 58(4):171-82. PubMed ID: 10077736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentiation by yohimbine of alpha-adrenoceptor-mediated vasoconstriction in response to clonidine in the rabbit ear vein.
    Zhao D; Ren LM; Lu HG; Zhang X
    Eur J Pharmacol; 2008 Jul; 589(1-3):201-5. PubMed ID: 18534573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet beta-adrenoceptors.
    Kerry R; Scrutton MC
    Br J Pharmacol; 1983 Jul; 79(3):681-91. PubMed ID: 6140045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of imidazoline and nonimidazoline α-adrenoceptor agonists and antagonists, including xylazine, medetomidine, dexmedetomidine, yohimbine, and atipamezole, on aggregation of feline platelets.
    Matsukawa T; Hikasa Y
    Am J Vet Res; 2020 Feb; 81(2):159-171. PubMed ID: 31985287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of alpha adrenergic agents on human platelet aggregation.
    Hsu CY; Knapp DR; Halushka PV
    J Pharmacol Exp Ther; 1979 Mar; 208(3):366-70. PubMed ID: 34707
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central alpha-adrenoceptor subtypes involved in the emetic pathway in cats.
    Hikasa Y; Akiba T; Iino Y; Matsukura M; Takase K; Ogasawara S
    Eur J Pharmacol; 1992 Dec; 229(2-3):241-51. PubMed ID: 1362706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood platelet adrenoceptor: aggregatory and antiaggregatory activity of imidazoline drugs.
    Petrusewicz J; Kaliszan R
    Pharmacology; 1986; 33(5):249-55. PubMed ID: 3797465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat.
    John GW; Doxey JC; Walter DS; Reid JL
    Br J Pharmacol; 1990 Aug; 100(4):699-704. PubMed ID: 1976400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of dog platelet alpha-adrenergic receptor: lack of in vivo down regulation by adrenergic agonist treatments.
    Villeneuve A; Berlan M; Lafontan M; Montastruc JL
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 81(1):181-7. PubMed ID: 2861047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of postsynaptic alpha-adrenoceptors in the isolated rat tail artery.
    Savino EA; Varela A
    Arch Int Pharmacodyn Ther; 1991; 309():137-46. PubMed ID: 1679620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of alpha1-adrenoceptor subtypes mediating vasoconstriction in human umbilical vein.
    Errasti AE; Velo MP; Torres RM; Sardi SP; Rothlin RP
    Br J Pharmacol; 1999 Jan; 126(2):437-42. PubMed ID: 10077236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic responses in human platelets. Comparison between aggregation, secretion and cytosolic Ca2+ concentration.
    Thompson NT; Scrutton MC; Wallis RB
    Eur J Biochem; 1986 Dec; 161(2):399-408. PubMed ID: 3490977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenoceptor-activation of oxygen consumption in rat parotid acini.
    Glenert U; Nauntofte B
    Pharmacol Toxicol; 1990 Apr; 66(4):266-72. PubMed ID: 1973537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alpha adrenoceptor subtypes involved in the emetic action in dogs.
    Hikasa Y; Ogasawara S; Takase K
    J Pharmacol Exp Ther; 1992 May; 261(2):746-54. PubMed ID: 1349647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adrenoceptor profile of blood vessels in the knee joint of the rabbit.
    Ferrell WR; Khoshbaten A
    J Physiol; 1989 Jul; 414():377-83. PubMed ID: 2575163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha 2-adrenoceptor in HT29 human colon adenocarcinoma cell-line: study of [3H](-)-adrenaline binding.
    Sénard JM; Mauriège P; Daviaud D; Paris H
    Eur J Pharmacol; 1989 Mar; 162(2):225-36. PubMed ID: 2566497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical assessment of the platelet adenylate cyclase system as a potential model for testing alpha 2 adrenergic activity.
    Ferry N; Henry D; Battais E; Mary A; Bonne C; Hanoune J
    Biochem Pharmacol; 1986 May; 35(9):1511-6. PubMed ID: 2871841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.